- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.90 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 2 x H4B: 5,6,7,8-TETRAHYDROBIOPTERIN(Non-covalent)
H4B.2: 13 residues within 4Å:- Chain A: S.62, V.64, R.325, A.406, W.407
- Chain B: W.405, F.420, H.421, Q.422, E.423
- Ligands: HEM.1, 01.3, GOL.9
10 PLIP interactions:9 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:R.325, A:R.325, A:A.406, A:W.407
- Water bridges: A:S.62, A:L.63
- pi-Stacking: A:W.407, A:W.407
- pi-Cation interactions: A:W.407
- Hydrophobic interactions: B:E.423
H4B.15: 14 residues within 4Å:- Chain A: W.34, W.405, F.420, H.421, Q.422, E.423
- Chain B: S.62, V.64, R.325, A.406, W.407
- Ligands: HEM.14, 01.16, GOL.20
9 PLIP interactions:8 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:R.325, B:R.325, B:A.406, B:W.407
- Water bridges: B:L.63, B:W.407
- pi-Stacking: B:W.407, B:W.407
- Hydrophobic interactions: A:E.423
- 2 x 01: (6M)-6-{5-[(4,4-difluoropiperidin-1-yl)methyl]-2,3-difluorophenyl}-4-methylpyridin-2-amine
01.3: 17 residues within 4Å:- Chain A: Q.207, P.294, V.296, F.313, S.314, G.315, W.316, Y.317, M.318, E.321, R.325, N.326, R.332
- Ligands: HEM.1, H4B.2, GOL.9, CL.10
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:P.294, A:F.313, A:R.325
- Hydrogen bonds: A:M.318, A:E.321
01.16: 16 residues within 4Å:- Chain B: Q.207, P.294, V.296, F.313, S.314, G.315, W.316, Y.317, M.318, E.321, R.325, N.326, R.332
- Ligands: HEM.14, H4B.15, CL.21
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:P.294, B:F.313, B:R.325
- Hydrogen bonds: B:M.318, B:E.321
- Water bridges: B:R.332
- 6 x BTB: 2-[BIS-(2-HYDROXY-ETHYL)-AMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-covalent)
BTB.4: 5 residues within 4Å:- Chain A: W.282, V.341, C.342, D.344
- Ligands: GD3.11
2 PLIP interactions:2 interactions with chain A- Water bridges: A:D.344
- Salt bridges: A:D.344
BTB.5: 3 residues within 4Å:- Chain A: E.337, T.347, R.348
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:E.337, A:T.347
- Water bridges: A:T.347, A:W.354
BTB.6: 3 residues within 4Å:- Chain A: D.257, E.258, P.259
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:D.257, A:E.258
- Salt bridges: A:E.258
BTB.17: 3 residues within 4Å:- Chain B: T.279, E.281
- Ligands: GD3.22
2 PLIP interactions:2 interactions with chain B- Water bridges: B:T.279
- Salt bridges: B:E.281
BTB.18: 2 residues within 4Å:- Chain B: D.257, E.258
2 PLIP interactions:2 interactions with chain B- Water bridges: B:E.258
- Salt bridges: B:E.258
BTB.23: 6 residues within 4Å:- Chain B: W.282, A.285, L.286, D.338, C.342
- Ligands: GD3.24
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:W.282
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.7: 1 residues within 4Å:- Chain A: E.127
No protein-ligand interaction detected (PLIP)GOL.8: 1 residues within 4Å:- Chain A: G.197
No protein-ligand interaction detected (PLIP)GOL.9: 6 residues within 4Å:- Chain A: V.64, R.325, H.331
- Chain B: W.34
- Ligands: H4B.2, 01.3
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.325, A:H.331
GOL.13: 2 residues within 4Å:- Chain A: D.344, L.345
No protein-ligand interaction detected (PLIP)GOL.19: 1 residues within 4Å:- Chain B: E.337
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.337
GOL.20: 6 residues within 4Å:- Chain A: W.34
- Chain B: V.64, R.325, H.331, W.407
- Ligands: H4B.15
4 PLIP interactions:3 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:R.325, B:H.331
- Water bridges: B:D.329, A:H.421
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- 3 x GD3: GADOLINIUM ION(Non-functional Binders)(Non-covalent)
GD3.11: 1 residues within 4Å:- Ligands: BTB.4
No protein-ligand interaction detected (PLIP)GD3.22: 3 residues within 4Å:- Chain B: T.279, E.281
- Ligands: BTB.17
3 PLIP interactions:2 interactions with chain B, 1 Ligand-Water interactions- Metal complexes: B:T.279, B:E.281, H2O.12
GD3.24: 1 residues within 4Å:- Ligands: BTB.23
No protein-ligand interaction detected (PLIP)- 1 x ZN: ZINC ION(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Vasu, D. et al., Truncated pyridinylbenzylamines: Potent, selective, and highly membrane permeable inhibitors of human neuronal nitric oxide synthase. Bioorg.Med.Chem. (2025)
- Release Date
- 2025-04-30
- Peptides
- Nitric oxide synthase, endothelial: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
SMTL ID : 9cwj.1 (1 other biounit)
Structure of human endothelial nitric oxide synthase heme domain bound with 6-(5-((4,4-difluoropiperidin-1-yl)methyl)-2,3-difluorophenyl)-4-methylpyridin-2-amine dihydrochloride
Nitric oxide synthase, endothelial
Related Entries With Identical Sequence
4d1o.1 | 4d1p.1 | 5uo8.1 | 5uo8.2 | 5uo9.1 | 5uo9.2 | 5uoa.1 | 5uob.1 | 5uob.2 | 5uoc.1 | 5uoc.2 | 5vvb.1 | 5vvb.2 | 5vvc.1 | 5vvc.2 | 5vvd.1 | 5vvd.2 | 6av6.1 | 6av6.2 | 6av7.1 | 6av7.2 | 6cie.1 | 6cie.2 | 6cif.1 | 6cif.2 | 6nh1.1 | 6nh1.2 | 6nh2.1 | 6nh2.2 | 6nh3.1 more...less...6nh3.2 | 6nh4.1 | 6nh4.2 | 6nh5.1 | 6nh5.2 | 6nh6.1 | 6nh6.2 | 6nh7.1 | 6nh8.1 | 6nh8.2 | 6nhf.1 | 6nhf.2 | 6pou.1 | 6pou.2 | 6pou.3 | 6pov.1 | 6pov.2 | 6pow.1 | 6pow.2 | 6pox.1 | 6pox.2 | 6poy.1 | 6poy.2 | 6poz.1 | 6poz.2 | 6pp0.1 | 6pp0.2 | 6pp1.1 | 6pp1.2 | 6pp2.1 | 6pp2.2 | 6pp3.1 | 6pp3.2 | 6pp4.1 | 6pp4.2 | 7m56.1 | 7tsg.1 | 7tsg.2 | 7tsh.1 | 7tsh.2 | 7tsi.1 | 7tsi.2 | 7tsk.1 | 7tsk.2 | 7tsl.1 | 7tsl.2 | 7tsm.1 | 7tsm.2 | 7tsn.1 | 7tsn.2 | 7tso.1 | 7tso.2 | 7tsp.1 | 7tsp.2 | 7uao.1 | 7uao.2 | 8fgn.1 | 8fgn.2 | 8fgo.1 | 8fgo.2 | 8fgp.1 | 8fgp.2 | 8fgq.1 | 8fgq.2 | 8fgr.1 | 8fgr.2 | 8fgs.1 | 8fgs.2 | 8fgt.1 | 8fgt.2 | 8fgu.1 | 8fgu.2 | 8ufr.1 | 8ufr.2 | 8ufu.1 | 8ufu.2 | 9cw2.1 | 9cw2.2 | 9cw4.1 | 9cw4.2 | 9cw5.1 | 9cw5.2 | 9cw6.1 | 9cw6.2 | 9cw7.1 | 9cw7.2 | 9cw8.1 | 9cw8.2 | 9cw9.1 | 9cw9.2 | 9cwd.1 | 9cwd.2 | 9cwi.1 | 9cwi.2 | 9cwj.2 | 9cwk.1 | 9cwk.2